1,705
Views
50
CrossRef citations to date
0
Altmetric
Review

Alterations of DNA methylome in human bladder cancer

, &
Pages 1013-1022 | Received 09 Jul 2013, Accepted 27 Jul 2013, Published online: 06 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kristina M. Jordahl, Amanda I. Phipps, Timothy W. Randolph, Hilary A. Tindle, Simin Liu, Lesley F. Tinker, Karl T. Kelsey, Emily White & Parveen Bhatti. (2019) Differential DNA methylation in blood as a mediator of the association between cigarette smoking and bladder cancer risk among postmenopausal women. Epigenetics 14:11, pages 1065-1073.
Read now
Brittany Bunch, Nithya Krishnan, Rebecca D. Greenspan, Swathi Ramakrishnan, Kristopher Attwood, Li Yan, Qianya Qi, Dan Wang, Carl Morrison, Angela Omilian, Wiam Bshara, Roberto Pili, Donald L. Trump, Candace Johnson & Anna Woloszynska. (2019) TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC). Cell Cycle 18:17, pages 2055-2066.
Read now
Mark O. Kitchen, Richard T. Bryan, Richard D. Emes, John R. Glossop, Christopher Luscombe, K. K. Cheng, Maurice P. Zeegers, Nicholas D. James, Adam J. Devall, Charles A. Mein, Lyndon Gommersall, Anthony A. Fryer & William E. Farrell. (2016) Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer . Epigenetics 11:3, pages 237-246.
Read now

Articles from other publishers (47)

Daryl Thompson, Nathan Lawrentschuk & Damien Bolton. (2023) New Approaches to Targeting Epigenetic Regulation in Bladder Cancer. Cancers 15:6, pages 1856.
Crossref
Ana Mafalda Rasteiro, Eva Sá e Lemos, Paula A. Oliveira & Rui M. Gil da Costa. (2022) Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy. Veterinary Sciences 9:3, pages 107.
Crossref
Ahmad Besaratinia, Amanda Caceres & Stella Tommasi. (2022) DNA Hydroxymethylation in Smoking-Associated Cancers. International Journal of Molecular Sciences 23:5, pages 2657.
Crossref
Yufeng Guo, Jianjian Yin, Yuanheng Dai, Yudong Guan, Pinjin Chen, Yongqiang Chen, Chenzheng Huang, Yong-Jie Lu, Lirong Zhang & Dongkui Song. (2021) A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Francesco Pierconti, Maurizio Martini, Tonia Cenci, Vincenzo Fiorentino, Emilio Sacco, Riccardo Bientinesi, Dario Pugliese, Roberto Iacovelli, Giovanni Schinzari, Luigi Maria Larocca & Pier Francesco Bassi. (2021) Methylation study of the Paris system for reporting urinary (TPS) categories. Journal of Clinical Pathology 74:2, pages 102-105.
Crossref
Andrew W. Caliri, Stella Tommasi & Ahmad Besaratinia. (2021) Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutation Research/Reviews in Mutation Research 787, pages 108365.
Crossref
Chanchai Boonla. 2021. Cancer. Cancer 67 75 .
Payam Behzadi. 2021. Genetic Polymorphism and cancer susceptibility. Genetic Polymorphism and cancer susceptibility 281 317 .
Peihua Liu, Longxiang Wu, Harripersaud Chand, Chao Li, Xiheng Hu & Yangle Li. (2020) Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer. Life Sciences 261, pages 118311.
Crossref
Christina U. Köhler, Michael Walter, Kerstin Lang, Sabine Plöttner, Florian Roghmann, Joachim Noldus, Andrea Tannapfel, Yu Chun Tam, Heiko U. Käfferlein & Thomas Brüning. (2020) In-Vitro Identification and In-Vivo Confirmation of DNA Methylation Biomarkers for Urothelial Cancer. Biomedicines 8:8, pages 233.
Crossref
Pratik M.S. Gurung, Abigail R. Barnett, Jayne S. Wilson, John Hudson, Douglas G. Ward, Edward M. Messing & Richard T. Bryan. (2020) Prognostic DNA Methylation Biomarkers in High-risk Non–muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation. European Urology Focus 6:4, pages 683-697.
Crossref
Jayoung Kim, Won Tae Kim & Wun-Jae Kim. (2020) Advances in urinary biomarker discovery in urological research. Investigative and Clinical Urology 61:Suppl 1, pages S8.
Crossref
Michèle J. Hoffmann, Helge Taubert & Kerstin Junker. 2020. Uroonkologie. Uroonkologie 1 20 .
A. Wojtczyk-Miaskowska & B. Schlichtholz. (2019) Tobacco carcinogens and the methionine metabolism in human bladder cancer. Mutation Research/Reviews in Mutation Research 782, pages 108281.
Crossref
Yinghui Yu, Hui Cao, Mengmeng Zhang, Fang Shi, Rui Wang & Xin Liu. (2018) Prognostic value of DNA methylation for bladder cancer. Clinica Chimica Acta 484, pages 207-212.
Crossref
Kristina M. Jordahl, Timothy W. Randolph, Xiaoling Song, Cassandra L. Sather, Lesley F. Tinker, Amanda I. Phipps, Karl T. Kelsey, Emily White & Parveen Bhatti. (2018) Genome-Wide DNA Methylation in Prediagnostic Blood and Bladder Cancer Risk in the Women's Health Initiative. Cancer Epidemiology, Biomarkers & Prevention 27:6, pages 689-695.
Crossref
Clémence Pinel, Barbara Prainsack & Christopher McKevitt. (2017) Markers as mediators: A review and synthesis of epigenetics literature. BioSocieties 13:1, pages 276-303.
Crossref
Tetsuya Shindo, Takashi Shimizu, Masanori Nojima, Takeshi Niinuma, Reo Maruyama, Hiroshi Kitajima, Masahiro Kai, Naoki Itoh, Hiromu Suzuki & Naoya Masumori. (2018) Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: A 2-Center Prospective Study. Urology 113, pages 71-78.
Crossref
Lars Erichsen, Foued Ghanjati, Agnes Beermann, Cedric Poyet, Thomas Hermanns, Wolfgang A. Schulz, Hans-Helge Seifert, Peter J. Wild, Lorenz Buser, Alexander Kröning, Stefan Braunstein, Martin Anlauf, Silvia Jankowiak, Mohamed Hassan, Marcelo L. Bendhack, Marcos J. Araúzo-Bravo & Simeon Santourlidis. (2018) Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Scientific Reports 8:1.
Crossref
Michal Chovanec, Fadi Taza, Maitri Kalra, Noah Hahn, Kenneth P. Nephew, Michael J. Spinella & Costantine Albany. (2017) Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review. Targeted Oncology 13:1, pages 49-60.
Crossref
Stella Tommasi & Ahmad Besaratinia. 2018. Urothelial Carcinoma. Urothelial Carcinoma 29 41 .
Kathleen Conway, Sharon N. Edmiston, Eloise Parrish, Christopher Bryant, Chiu-Kit Tse, Theresa Swift-Scanlan, Lauren E. McCullough & Pei Fen Kuan. (2017) Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study. Breast Cancer Research and Treatment 163:2, pages 349-361.
Crossref
Alexander P. Glaser, Damiano Fantini, Ali Shilatifard, Edward M. Schaeffer & Joshua J. Meeks. (2017) The evolving genomic landscape of urothelial carcinoma. Nature Reviews Urology 14:4, pages 215-229.
Crossref
Christopher M. Fulkerson, Deepika Dhawan, Timothy L. Ratliff, Noah M. Hahn & Deborah W. Knapp. (2017) Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs. International Journal of Genomics 2017, pages 1-9.
Crossref
Wolfgang A. Schulz & Mich?le J. Hoffmann. 2017. Encyclopedia of Cancer. Encyclopedia of Cancer 4741 4747 .
Wolfgang A Schulz & Wolfgang Goering. (2016) DNA methylation in urothelial carcinoma. Epigenomics 8:10, pages 1415-1428.
Crossref
Pierre-Antoine Dugué, Maree T Brinkman, Roger L Milne, Ee Ming Wong, Liesel M FitzGerald, Julie K Bassett, Jihoon E Joo, Chol-Hee Jung, Enes Makalic, Daniel F Schmidt, Daniel J Park, Jessica Chung, Anthony D Ta, Damien M Bolton, Andrew Lonie, Anthony Longano, John L Hopper, Gianluca Severi, Richard Saffery, Dallas R English, Melissa C Southey & Graham G Giles. (2016) Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case–control study. British Journal of Cancer 115:6, pages 664-673.
Crossref
Alexandra Masson-Lecomte, Evangelina López de Maturana, Michael E. Goddard, Antoni Picornell, Marta Rava, Anna González-Neira, Mirari Márquez, Alfredo Carrato, Adonina Tardon, Josep Lloreta, Montserrat Garcia-Closas, Debra Silverman, Nathaniel Rothman, Manolis Kogevinas, Yves Allory, Stephen J. Chanock, Francisco X. Real & Núria Malats. (2016) Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment. Cancer Epidemiology, Biomarkers & Prevention 25:7, pages 1144-1150.
Crossref
Xinchao Wu, Dong Liu, Dan Tao, Wei Xiang, Xingyuan Xiao, Miao Wang, Liang Wang, Gang Luo, Yawei Li, Fuqing Zeng & Guosong Jiang. (2016) BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer. Molecular Cancer Therapeutics 15:5, pages 1029-1042.
Crossref
HYUNG-YOON YOON, YONG-JUNE KIM, JI SANG KIM, YOUNG-WON KIM, HO WON KANG, WON TAE KIM, SEOK-JOONG YUN, KEUN HO RYU, SANG-CHEOL LEE & WUN-JAE KIM. (2016) RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer. Oncology Reports 35:2, pages 1195-1203.
Crossref
Yong-June KimWun-Jae Kim. (2016) Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?. Investigative and Clinical Urology 57:Suppl 1, pages S77.
Crossref
Hyung-Yoon Yoon, Sung Pil Seo, Sang Keun Lee, Ho Won Kang, Won Tae Kim, Dong Hee Ryu, Seok-Joong Yun, Sang-Cheol Lee, Wun-Jae Kim & Yong-June Kim. (2015) Association of GATA5 methylation with clinocopathological characteristics in non-muscle invasive bladder cancer. Journal of Biomedical Research 16:4, pages 146-151.
Crossref
Emmanouil Magiorkinis & Aristidis Diamantis. (2015) The fascinating story of urine examination: From uroscopy to the era of microscopy and beyond. Diagnostic Cytopathology 43:12, pages 1020-1036.
Crossref
Xinsheng Wang, Qiaoli Wu, Bin Xu, Pengfei Wang, Weijia Fan, Ying Cai, Xinquan Gu & Fanping Meng. (2015) miR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1. FEBS Journal 282:22, pages 4376-4388.
Crossref
Qi Liao, Weiling He, Jianfa Liu, Yi Cen, Liang Luo, Chengliang Yu, Yang Li, Sitong Chen & Shiwei Duan. (2015) Identification and functional annotation of lncRNA genes with hypermethylation in colorectal cancer. Gene 572:2, pages 259-265.
Crossref
Joseph J. Fantony, Michael R. Abern, Ajay Gopalakrishna, Richmond Owusu, Kae Jack Tay, Raymond S. Lance & Brant A. Inman. (2015) Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. Urologic Oncology: Seminars and Original Investigations 33:9, pages 387.e1-387.e6.
Crossref
Xiaoying Zhang, Conghui Han & Jantai He. (2015) Recent Advances in the Diagnosis and Management of Bladder Cancer. Cell Biochemistry and Biophysics 73:1, pages 11-15.
Crossref
Christopher M. Fulkerson & Deborah W. Knapp. (2015) Management of transitional cell carcinoma of the urinary bladder in dogs: A review. The Veterinary Journal 205:2, pages 217-225.
Crossref
Chiraphat Kloypan, Monpicha Srisa-art, Apiwat Mutirangura & Chanchai Boonla. (2015) LINE-1 hypomethylation induced by reactive oxygen species is mediated via depletion of S-adenosylmethionine. Cell Biochemistry and Function 33:6, pages 375-384.
Crossref
G. Niegisch, M.J. Hoffmann, E.A. Koutsogiannouli & W.A. Schulz. (2015) Epigenetik des UrothelkarzinomsEpigenetics in urothelial cancer. Der Urologe 54:4, pages 526-532.
Crossref
Akshay Bhat, Andreas Heinzel, Bernd Mayer, Paul Perco, Irmgard M?hlberger, Holger Husi, Axel S. Merseburger, Jerome Zoidakis, Antonia Vlahou, Joost P. Schanstra, Harald Mischak & Vera Jankowski. (2015) Protein Interactome of Muscle Invasive Bladder Cancer. PLOS ONE 10:1, pages e0116404.
Crossref
Young-Won Kim, Hyung-Yoon Yoon, Sung Pil Seo, Sang Keun Lee, Ho Won Kang, Won Tae Kim, Heui Je Bang, Dong Hee Ryu, Seok-Joong Yun, Sang-Cheol Lee, Wun-Jae Kim & Yong-June Kim. (2015) Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer . Disease Markers 2015, pages 1-6.
Crossref
Wolfgang A. Schulz, Evangelia A. Koutsogiannouli, Günter Niegisch & Michèle J. Hoffmann. 2015. Cancer Epigenetics. Cancer Epigenetics 183 215 .
A. Besaratinia & S. Tommasi. (2014) Epigenetics of human melanoma: promises and challenges. Journal of Molecular Cell Biology 6:5, pages 356-367.
Crossref
Alice Gutjahr & Shuang-yong Xu. (2014) Engineering nicking enzymes that preferentially nick 5-methylcytosine-modified DNA. Nucleic Acids Research 42:9, pages e77-e77.
Crossref
D. W. Knapp, J. A. Ramos-Vara, G. E. Moore, D. Dhawan, P. L. Bonney & K. E. Young. (2014) Urinary Bladder Cancer in Dogs, a Naturally Occurring Model for Cancer Biology and Drug Development. ILAR Journal 55:1, pages 100-118.
Crossref
Wolfgang A. Schulz & Michèle J. Hoffmann. 2016. Encyclopedia of Cancer. Encyclopedia of Cancer 1 8 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.